Akebia Therapeutics Statistics

Total Valuation

AKBA has a market cap or net worth of $874.98 million. The enterprise value is $933.57 million.

Market Cap	874.98M
Enterprise Value	933.57M

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

AKBA has 265.15 million shares outstanding. The number of shares has increased by 16.95% in one year.

Current Share Class	265.15M
Shares Outstanding	265.15M
Shares Change (YoY)	+16.95%
Shares Change (QoQ)	+12.21%
Owned by Insiders (%)	2.02%
Owned by Institutions (%)	41.01%
Float	259.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.76
Forward PS	5.45
PB Ratio	29.70
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.58
EV / EBITDA	39.98
EV / EBIT	233.45
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.98, with a Debt / Equity ratio of 6.70.

Current Ratio	1.98
Quick Ratio	1.77
Debt / Equity	6.70
Debt / EBITDA	6.91
Debt / FCF	n/a
Interest Coverage	0.14

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	0.88%
Return on Invested Capital (ROIC)	1.69%
Return on Capital Employed (ROCE)	1.76%
Revenue Per Employee	$1.13M
Profits Per Employee	-$201,569
Employee Count	181
Asset Turnover	0.72
Inventory Turnover	1.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +168.29% in the last 52 weeks. The beta is 0.96, so AKBA's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	+168.29%
50-Day Moving Average	3.68
200-Day Moving Average	2.48
Relative Strength Index (RSI)	41.41
Average Volume (20 Days)	3,900,429

Short Selling Information

The latest short interest is 24.54 million, so 9.25% of the outstanding shares have been sold short.

Short Interest	24.54M
Short Previous Month	25.37M
Short % of Shares Out	9.25%
Short % of Float	9.44%
Short Ratio (days to cover)	7.57

Income Statement

In the last 12 months, AKBA had revenue of $203.73 million and -$36.48 million in losses. Loss per share was -$0.16.

Revenue	203.73M
Gross Profit	169.55M
Operating Income	4.00M
Pretax Income	-40.44M
Net Income	-36.48M
EBITDA	23.35M
EBIT	4.00M
Loss Per Share	-$0.16

Full Income Statement

Balance Sheet

The company has $137.31 million in cash and $195.90 million in debt, giving a net cash position of -$58.59 million or -$0.22 per share.

Cash & Cash Equivalents	137.31M
Total Debt	195.90M
Net Cash	-58.59M
Net Cash Per Share	-$0.22
Equity (Book Value)	29.22M
Book Value Per Share	0.11
Working Capital	115.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.40 million and capital expenditures -$148,000, giving a free cash flow of -$2.55 million.

Operating Cash Flow	-2.40M
Capital Expenditures	-148,000
Free Cash Flow	-2.55M
FCF Per Share	-$0.01

Full Cash Flow Statement

Margins

Gross margin is 83.22%, with operating and profit margins of 1.96% and -17.91%.

Gross Margin	83.22%
Operating Margin	1.96%
Pretax Margin	-17.91%
Profit Margin	-17.91%
EBITDA Margin	11.46%
EBIT Margin	1.96%
FCF Margin	n/a

Dividends & Yields

AKBA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.95%
Shareholder Yield	-16.95%
Earnings Yield	-4.17%
FCF Yield	-0.29%

Analyst Forecast

The average price target for AKBA is $6.90, which is 109.09% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.90
Price Target Difference	109.09%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	25.30%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AKBA has an Altman Z-Score of -4.88 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.88
Piotroski F-Score	4